Xarelto plaintiffs are asking that federal lawsuits be consolidated in East St. Louis, IL. Bloomberg reports that there are approximately 50 cases filed in 15 different federal courts to date. The plaintiffs have requested that a multidistrict litigation be formed to help move the cases along more efficiently.
Xarelto is a blood thinner that was first approved for use in 2011. The medication is intended to prevent blood clots in patients undergoing ...
continue reading...
An antibiotic class known as fluoroquinolones has been linked to serious nerve damage when taken orally or by injection. The condition is known as peripheral neuropathy. It can be severe, comes on suddenly, and may be permanent. A story posted on WebMD details how the U.S. Food and Drug Administration (FDA) elevated the warnings regarding these drugs and their potential adverse effects.
Fluoroquinolones are commonly used antibiotics. They are frequently used for the treatment of respiratory ...
continue reading...
According to reports in The New England Journal of Medicine and from researchers at Vanderbilt University, seemingly benign masses found in the breast tissue of women poses a greater risk of cancer than previously thought. The type of mass is identified as atypical hyperplasia, or atypia. The condition is not a cancer but is an accumulation of abnormal cells. About 100,000 women in the United States are found to have one of these ...
The U.S. Food and Drug Administration (FDA) has approved a total of four prescription drugs for obesity since 2012. In a population where two-thirds of the adults are considered overweight or obese, it is not surprising that there is such a demand for the medications. The most recent drug to gain FDA approval is called Saxenda. The drug was approved in December, 2014, and insurance companies have already stated that they will not ...
Ongoing litigation against the pharmaceutical giant Johnson & Johnson (J&J) involves the allegations of improper and deceitful marketing of their antipsychotic drug, Risperdal. A Risperdal lawsuit being heard in the Philadelphia Common Pleas Court may take an interesting turn with the involvement of a former commissioner from the U.S. Food and Drug Administration (FDA). A recent article from Philly.com discusses the possibility that the former FDA commissioner will be called to testify against Johnson & ...
The FDA released a statement discouraging the use of power morcellators in gynecological procedures because of significant cancer risks. A story by CBS Pittsburgh reports of a new study by Columbia University that further confirmed that power morcellators can spread undiagnosed stage 1 cancer.
The Columbia University study concluded that an estimated 1 in 368 women have uterine cancer at the time they undergo a gynecologic procedure. As a result, doctors may be ...
continue reading...
